Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the design of modulators targeting neurotransmitter receptors and enzymes involved in neurological disorders. The compound's rigid cyclopropane ring and halogenated aryl group enhance binding selectivity and metabolic stability, making it valuable in medicinal chemistry for optimizing drug candidates. It is also employed in research for developing novel antidepressants, anxiolytics, and antipsychotics.